基本描述

别名	β-Ala \| 3-氨基丙酸
英文别名	ALANINE, BETA \| Alanine, beta- \| BETA ALANINE [USP-RS] \| EC 203-536-5 \| HY-N0230 \| omega-Aminopropionate \| Q310919 \| b-Aminopropanoic acid \| .BETA.-ALANINE [MI] \| 11P2JDE17B \| b-Aminopropionate \| 3-Aminopropionsaeure \| MFCD00008200 \| b-Aminopropanoate \| b
规格或纯度	Moligand™, ≥99%
英文名称	β-Alanine
生化机理	抑制性甘氨酸受体的非特异性内源性激动剂。比牛磺酸更具选择性。还可以区分GABA转运蛋白（rGAT-2，hGAT-3，rGAT-3，hBGT-3和hGAT-1的IC50值分别为19、58、110、1320和5690μM）。也是MRGPRD激动剂。
运输条件	常规运输
产品介绍	溶于水，水中溶解度:55 g/100ml (25°C)，微溶于乙醇，不溶于乙醚、丙酮和有机溶剂。50%水溶液pH值6.0-7.3。其氢氯化物为白色片状或叶片状结晶，其氯化铂盐为黄色片晶。内源性β-氨基酸，非选择性甘氨酸受体激动剂，G-蛋白偶联孤儿受体（TGR7，MrgD）配体。靠支持海洋生物的渗透稳定，β-氨基酸流出起到细胞保护作用。 β-Alanine has been used as a ligand for the orphan MAS-related receptor.[1] It has also been used in culture media used for certain strains of yeast to test for β-alanine auxotrophy.
纯度	≥99%

关联靶点（人）

MRGPRD Tchem Mas相关G蛋白偶联受体成员D(Mas-related G-protein coupled receptor member D) (3 活性数据)

点击查看靶蛋白信息： MRGPRD

活性类型	活性值-log(M)	作用机制	期刊	参考文献(PubMed IDs)

SLC6A1 Tclin GABA transporter 1 (308 活性数据)

点击查看靶蛋白信息： SLC6A1

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 活性数据)

点击查看靶蛋白信息： GRIN1

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

SLC6A11 Tchem GABA transporter 3 (176 活性数据)

点击查看靶蛋白信息： SLC6A11

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

CYP2D6 Tclin Cytochrome P450 2D6 (33882 活性数据)

点击查看靶蛋白信息： CYP2D6

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

CYP1A2 Tchem Cytochrome P450 1A2 (26471 活性数据)

点击查看靶蛋白信息： CYP1A2

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

CYP2C9 Tchem Cytochrome P450 2C9 (32119 活性数据)

点击查看靶蛋白信息： CYP2C9

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

CYP2C19 Tchem Cytochrome P450 2C19 (29246 活性数据)

点击查看靶蛋白信息： CYP2C19

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

CYP3A4 Tclin Cytochrome P450 3A4 (53859 活性数据)

点击查看靶蛋白信息： CYP3A4

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

RGS4 Tchem Regulator of G-protein signaling 4 (13867 活性数据)

点击查看靶蛋白信息： RGS4

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

SLC36A1 Tchem Proton-coupled amino acid transporter 1 (102 活性数据)

点击查看靶蛋白信息： SLC36A1

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

关联靶点（其它种属）

Slc6a13 GABA transporter 2 (37 活性数据)

点击查看靶蛋白信息： Slc6a13

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

Slc6a11 GABA transporter 4 (930 活性数据)

点击查看靶蛋白信息： Slc6a11

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

lef Anthrax lethal factor (7585 活性数据)

点击查看靶蛋白信息： lef

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

panC Pantothenate synthetase (234 活性数据)

点击查看靶蛋白信息： panC

活性类型	Relation	Activity value	Units	Action Type	期刊	PubMed Id	doi	Assay Aladdin ID

作用机制

作用机制	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	参考文献

名称和识别符

PubChem SID	488179503
EC号	203-536-5
分子类型	小分子
IIUPAC Name	3-aminopropanoic acid
INCHI	1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)
InChi Key	UCMIRNVEIXFBKS-UHFFFAOYSA-N
Smiles	C(CN)C(=O)O
Isomeric SMILES	C(CN)C(=O)O
分子量	89.09
Beilstein号	906793
Reaxy-Rn	906793
Reaxys-RN link address	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=906793&ln=

化学和物理性质

溶解性	溶于water, 最高浓度 (mg/mL): None, 最高浓度(mM): 100
密度	1.437
熔点	205°C
分子量	89.090 g/mol
XLogP3	-3.000
氢键供体数Hydrogen Bond Donor Count	2
氢键受体数Hydrogen Bond Acceptor Count	3
可旋转键计数Rotatable Bond Count	2
精确质量Exact Mass	89.0477 Da
单同位素质量Monoisotopic Mass	89.0477 Da
拓扑极表面积Topological Polar Surface Area	63.300 Å²
重原子数Heavy Atom Count	6
形式电荷Formal Charge	0
复杂度Complexity	52.800
同位素原子数Isotope Atom Count	0
定义的原子立体中心计数Defined Atom Stereocenter Count	0
未定义的原子立体中心计数Undefined Atom Stereocenter Count	0
定义的键立体中心计数Defined Bond Stereocenter Count	0
未定义的键立体中心计数Undefined Bond Stereocenter Count	0
所有立体化学键的总数The total count of all stereochemical bonds	0
共价键合单元计数Covalently-Bonded Unit Count	1

安全和危险性（GHS）

WGK Germany	3
Merck Index	205
个人防护装备	Eyeshields,Gloves,type N95 (US),type P1 (EN143) respirator filter

质检证书（CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):

输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！

找到27个结果

批号(Lot Number)	证书类型	货号
F2512055	分析证书	A105703
D2514006	分析证书	A105703
F2116346	分析证书	A105703
A2509031	分析证书	A105703
K2413112	分析证书	A105703
D2510023	分析证书	A105703
G2326094	分析证书	A105703
G2326099	分析证书	A105703
G2326100	分析证书	A105703
K2317208	分析证书	A105703
K2317209	分析证书	A105703
C2323078	分析证书	A105703
C2323084	分析证书	A105703
L2216178	分析证书	A105703
L2216179	分析证书	A105703
L2216180	分析证书	A105703
L2216181	分析证书	A105703
L2216182	分析证书	A105703
L2216183	分析证书	A105703
C2328240	分析证书	A105703
K2407153	分析证书	A105703
A2218157	分析证书	A105703
B2302293	分析证书	A105703
B2302294	分析证书	A105703
A2218137	分析证书	A105703
A2218149	分析证书	A105703
A2218150	分析证书	A105703

显示更多⌵

可替换产品

此产品的引用文献

如何在您的发表作品中引用阿拉丁的产品和网站? 引用文献检索

引用文献

1. Milasta S, Pediani J, Appelbe S, Trim S, Wyatt M, Cox P, Fidock M, Milligan G. (2006) Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD.. Mol Pharmacol, 69 (2): (479-91). [PMID:16282220]
2. Billups D et al.. (2013) Inducible presynaptic glutamine transport supports glutamatergic transmission at the calyx of held synapse.. J Neurosci, 33 (44): (17429-34). [PMID:24174676]
3. I M Karmanskiĭ. (1977-07-01) [Effect of pepsin on low density serum lipoproteins].. Voprosy meditsinskoi khimii, 23 ((4)): (530-534). [PMID:200005]
4. K C Kuo,T F Cole,C W Gehrke,T P Waalkes,E Borek. (1978-08-01) Dual-column cation-exchange chromatographic method for beta-aminoisobutyric acid and beta-alanine in biological samples.. Clinical chemistry, 24 ((8)): (1373-1380). [PMID:679461]
5. M R Johnson,S Barnes,D J Sweeny,R B Diasio. (1990-09-15) 2-Fluoro-beta-alanine, a previously unrecognized substrate for bile acid coenzyme A:amino acid:N-acyltransferase from human liver.. Biochemical pharmacology, 40 ((6)): (1241-1246). [PMID:2119585]
6. J D Shoemaker,W H Elliott. (1991-01-02) Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease.. Journal of chromatography, 562 ((1-2)): (125-138). [PMID:2026685]
7. J U Hibbard,G Pridjian,P F Whitington,A H Moawad. (1990-01-01) Taurine transport in the in vitro perfused human placenta.. Pediatric research, 27 ((1)): (80-84). [PMID:2296474]
8. M C Malet-Martino,J Bernadou,R Martino,J P Armand. (1988-01-01) 19F NMR spectrometry evidence for bile acid conjugates of alpha-fluoro-beta-alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humans.. Drug metabolism and disposition: the biological fate of chemicals, 16 ((1)): (78-84). [PMID:2894959]
9. B Holm,D W Nilsen,P Kierulf,H C Godal. (1985-01-01) Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma.. Thrombosis research, 37 ((1)): (165-176). [PMID:3983897]
10. J Aznar,J Gilabert,A Estelles,M A Fernandez,P Villa,J A Aznar. (1982-09-15) Evaluation of the soluble fibrin monomer complexes and other coagulation parameters in obstetric patients.. Thrombosis research, 27 ((6)): (691-701). [PMID:7179210]
11. B Di Blasio,V Pavone,A Lombardi,C Pedone,E Benedetti. (1993-07-01) Noncoded residues as building blocks in the design of specific secondary structures: symmetrically disubstituted glycines and beta-alanine.. Biopolymers, 33 ((7)): (1037-1049). [PMID:8343584]
12. Y Chen,T V Getchell,D L Sparks,M L Getchell. (1994-03-01) Cellular localization of carnosinase in the human nasal mucosa.. Acta oto-laryngologica, 114 ((2)): (193-198). [PMID:8203202]
13. S Sumi,K Kidouchi,S Ohba,Y Wada. (1995-10-20) Automated screening system for purine and pyrimidine metabolism disorders using high-performance liquid chromatography.. Journal of chromatography. B, Biomedical applications, 672 ((2)): (233-239). [PMID:8581129]
14. N Tamaki,S Sakata,K Matsuda. (2001-10-26) [Beta-alanine aminotransferases on pyrimidine catabolism].. Seikagaku. The Journal of Japanese Biochemical Society, 73 ((9)): (1151-1154). [PMID:11675999]
15. K M Gibson,D S M Schor,M Gupta,W S Guerand,H Senephansiri,T G Burlingame,H Bartels,B M Hogema,T Bottiglieri,W Froestl,O C Snead,M Grompe,C Jakobs. (2002-06-18) Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase.. Journal of neurochemistry, 81 ((1)): (71-79). [PMID:12067239]
16. André B P Van Kuilenburg,Alida E M Stroomer,Henk Van Lenthe,Nico G G M Abeling,Albert H Van Gennip. (2004-01-07) New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?. The Biochemical journal, 379 ((Pt 1)): (119-124). [PMID:14705962]
17. E E Champion,S J Mann,J D Glazier,C J P Jones,J M Rawlings,C P Sibley,S L Greenwood. (2004-07-31) System beta and system A amino acid transporters in the feline endotheliochorial placenta.. American journal of physiology. Regulatory, integrative and comparative physiology, 287 ((6)): (R1369-R1379). [PMID:15284084]
18. André B P van Kuilenburg,Rutger Meinsma,Eva Beke,Birgit Assmann,Antonia Ribes,Isabel Lorente,Rebekka Busch,Ertan Mayatepek,Nico G G M Abeling,Arno van Cruchten,Alida E M Stroomer,Henk van Lenthe,Lida Zoetekouw,Willem Kulik,Georg F Hoffmann,Thomas Voit,Ron A Wevers,Frank Rutsch,Albert H van Gennip. (2004-09-24) beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities.. Human molecular genetics, 13 ((22)): (2793-2801). [PMID:15385443]
19. Mark G Jones,Elizabeth Cooper,Saira Amjad,C Stewart Goodwin,Jeffrey L Barron,Ronald A Chalmers. (2005-07-05) Urinary and plasma organic acids and amino acids in chronic fatigue syndrome.. Clinica chimica acta; international journal of clinical chemistry, 361 ((1-2)): (150-158). [PMID:15992788]
20. Arun Sreekumar,Laila M Poisson,Thekkelnaycke M Rajendiran,Amjad P Khan,Qi Cao,Jindan Yu,Bharathi Laxman,Rohit Mehra,Robert J Lonigro,Yong Li,Mukesh K Nyati,Aarif Ahsan,Shanker Kalyana-Sundaram,Bo Han,Xuhong Cao,Jaeman Byun,Gilbert S Omenn,Debashis Ghosh,Subramaniam Pennathur,Danny C Alexander,Alvin Berger,Jeffrey R Shuster,John T Wei,Sooryanarayana Varambally,Christopher Beecher,Arul M Chinnaiyan. (2009-02-13) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.. Nature, 457 ((7231)): (910-914). [PMID:19212411]
21. Craig Sale,Bryan Saunders,Roger C Harris. (2010-01-22) Effect of beta-alanine supplementation on muscle carnosine concentrations and exercise performance.. Amino acids, 39 ((2)): (321-333). [PMID:20091069]
22. Wim Derave,Inge Everaert,Sam Beeckman,Audrey Baguet. (2010-03-05) Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training.. Sports medicine (Auckland, N.Z.), 40 ((3)): (247-263). [PMID:20199122]
23. Guilherme Giannini Artioli,Bruno Gualano,Abbie Smith,Jeffrey Stout,Antonio Herbert Lancha. (2010-05-19) Role of beta-alanine supplementation on muscle carnosine and exercise performance.. Medicine and science in sports and exercise, 42 ((6)): (1162-1173). [PMID:20479615]
24. K E Tiedje,K Stevens,S Barnes,D F Weaver. (2010-06-15) Beta-alanine as a small molecule neurotransmitter.. Neurochemistry international, 57 ((3)): (177-188). [PMID:20540981]
25. Hans F N Kvitvang,Trygve Andreassen,Tomas Adam,Silas G Villas-Bôas,Per Bruheim. (2011-03-11) Highly sensitive GC/MS/MS method for quantitation of amino and nonamino organic acids.. Analytical chemistry, 83 ((7)): (2705-2711). [PMID:21388201]
26. Wolfram Gronwald,Matthias S Klein,Raoul Zeltner,Bernd-Detlef Schulze,Stephan W Reinhold,Markus Deutschmann,Ann-Kathrin Immervoll,Carsten A Böger,Bernhard Banas,Kai-Uwe Eckardt,Peter J Oefner. (2011-03-11) Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.. Kidney international, 79 ((11)): (1244-1253). [PMID:21389975]
27. Iris Thondorf,Valerie Voigt,Sarah Schäfer,Sabine Gebauer,Katja Zebisch,Linda Laug,Matthias Brandsch. (2011-10-01) Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1).. Bioorganic & medicinal chemistry, 19 ((21)): (6409-6418). [PMID:21955456]
28. Julie Y Culbertson,Richard B Kreider,Mike Greenwood,Matthew Cooke. (2010-01-01) Effects of beta-alanine on muscle carnosine and exercise performance: a review of the current literature.. Nutrients, 2 ((1)): (75-98). [PMID:22253993]
29. John Caruso,Jessica Charles,Kayla Unruh,Rachel Giebel,Lexis Learmonth,William Potter. (2012-08-02) Ergogenic effects of β-alanine and carnosine: proposed future research to quantify their efficacy.. Nutrients, 4 ((7)): (585-601). [PMID:22852051]
30. Roger C Harris,Craig Sale. (2012-10-19) Beta-alanine supplementation in high-intensity exercise.. Medicine and sport science, 59 (1-17). [PMID:23075550]
31. Wilson I Gonsalves,Rajiv K Pruthi,Mrinal M Patnaik. (2013-05-04) The new oral anticoagulants in clinical practice.. Mayo Clinic proceedings, 88 ((5)): (495-511). [PMID:23639500]
32. Carolyn M Millar,David A Lane. (2013-05-04) Blocking direct inhibitor bleeding.. Blood, 121 ((18)): (3543-3544). [PMID:23640994]
33. Jeff S Healey,John Eikelboom,Sean Yang,Ellison Themeles,Stuart J Connolly,Salim Yusuf,James Douketis,Lars Wallentin,Jonas Oldgren,Hein Heidbuchel,Alvaro Avezum,Paul Reilly,Michael Ezekowitz. (2013-05-07) Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.. Circulation, 127 ((11)): (e506-e506). [PMID:23646374]
34. Sushil Allen Luis,Karl Poon,Chris Luis,Akhil Shukla,Nicholas Bett,Christian Hamilton-Craig. (2013-05-23) Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.. Circulation. Cardiovascular imaging, 6 ((3)): (491-492). [PMID:23696587]
35. Dirk Einecke. (2013-05-25) [Venous thromboembolism. Currently it is worthwhile to use anticoagulants longer].. MMW Fortschritte der Medizin, 155 ((6)): (26-27). [PMID:23700693]
36. Kenneth A Bauer. (2013-06-05) Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.. Stroke, 44 ((6 Suppl 1)): (S38-S40). [PMID:23709725]
37. H H Klein. (2013-06-06) [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].. Deutsche medizinische Wochenschrift (1946), 138 ((24)): (1309-1311). [PMID:23737116]
38. Sam Schulman. (2013-06-14) Extended anticoagulation in venous thromboembolism.. The New England journal of medicine, 368 ((24)): (2329-2329). [PMID:23758240]
39. Andrew J Franck,Jessica A Bovio. (2013-06-14) Extended anticoagulation in venous thromboembolism.. The New England journal of medicine, 368 ((24)): (2328-2329). [PMID:23758241]
40. Hannes Neuwirt,Andreas Kronbichler. (2013-06-19) Dabigatran pharmacokinetics--implications for treatment.. American journal of kidney diseases : the official journal of the National Kidney Foundation, 62 ((1)): (180-180). [PMID:23773843]
41. Inna Y Gong,Richard B Kim. (2013-06-29) Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.. The Canadian journal of cardiology, 29 ((7 Suppl)): (S24-S33). [PMID:23790595]
42. Robert G Hart,John W Eikelboom,K Scott Brimble,M Sean McMurtry,Alistair J Ingram. (2013-06-29) Stroke prevention in atrial fibrillation patients with chronic kidney disease.. The Canadian journal of cardiology, 29 ((7 Suppl)): (S71-S78). [PMID:23790601]
43. Doug Coyle,Kathryn Coyle,Chris Cameron,Karen Lee,Shannon Kelly,Sabine Steiner,George A Wells. (2013-06-26) Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 16 ((4)): (498-506). [PMID:23796283]
44. Jecko Thachil,Gill Pike,Lynne Keighley-Jones,Michael J Nash. (2013-06-27) Plasma dabigatran activity one week after discontinuation despite normal renal function.. The American journal of medicine, 126 ((8)): (e5-e6). [PMID:23800582]
45. Lawrence Baruch. (2013-07-03) Laboratory monitoring of anticoagulant medications: focus on novel oral anticoagulants.. Postgraduate medicine, 125 ((2)): (135-145). [PMID:23816779]
46. Adriano A Truffa,Renato D Lopes,L Kristin Newby. (2013-07-03) Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012.. Postgraduate medicine, 125 ((2)): (146-157). [PMID:23816780]
47. (2013-07-03) Dabigatran and mechanical valves: less effective and more risky than warfarin.. Prescrire international, 22 ((138)): (128-128). [PMID:23819180]
48. (2013-07-20) Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.. Prescrire international, 22 ((139)): (155-159). [PMID:23866358]
49. Roger C Harris,Trent Stellingwerff. (2013-08-01) Effect of β-alanine supplementation on high-intensity exercise performance.. Nestle Nutrition Institute workshop series, 76 (61-71). [PMID:23899755]
50. Jay Shavadia,Robert C Welsh. (2013-09-12) Acute management of ST-elevation myocardial infarction patients taking dabigatran.. The Canadian journal of cardiology, 29 ((11)): (1531-1531). [PMID:24021476]
51. Ramin Artang,Eric Rome,Jørn Dalsgaard Nielsen,Humberto J Vidaillet. (2013-10-01) Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors.. The American journal of cardiology, 112 ((12)): (1973-1979). [PMID:24075284]
52. Ammar Majeed,Hun-Gyu Hwang,Stuart J Connolly,John W Eikelboom,Michael D Ezekowitz,Lars Wallentin,Martina Brueckmann,Mandy Fraessdorf,Salim Yusuf,Sam Schulman. (2013-10-02) Management and outcomes of major bleeding during treatment with dabigatran or warfarin.. Circulation, 128 ((21)): (2325-2332). [PMID:24081972]
53. Waleed Ghanima,Dan Atar,Per Morten Sandset. (2013-10-03) New oral anticoagulants--a review.. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 133 ((18)): (1940-1945). [PMID:24084970]
54. Wayne L Chandler. (2013-10-15) Anticoagulation without monitoring.. American journal of clinical pathology, 140 ((5)): (606-607). [PMID:24124137]
55. Christina L Cove,Elaine M Hylek. (2013-10-25) An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.. Journal of the American Heart Association, 2 ((5)): (e000136-e000136). [PMID:24152980]
56. Su Emmanuelle Degirmenci,Annick Steib. (2013-10-31) [New direct oral anticoagulants and venous thromboprophylaxis].. La Revue du praticien, 63 ((7)): (976-979). [PMID:24167901]
57. Zachary D Goldberger,G Caleb Alexander. (2013-11-13) Digitalis use in contemporary clinical practice: refitting the foxglove.. JAMA internal medicine, 174 ((1)): (151-154). [PMID:24217624]
58. Wilma Potze,Freeha Arshad,Jelle Adelmeijer,Hans Blokzijl,Arie P van den Berg,Robert J Porte,Ton Lisman. (2013-11-14) Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.. British journal of haematology, 163 ((5)): (666-673). [PMID:24219333]
59. Thomas Mathew,Alexander Manuel Lobo,Gosala Raja Kukkuta Sarma,Raghunandan Nadig. (2013-11-23) A case of post varicella cortical venous thrombosis successfully treated with dabigatran.. Neurology India, 61 ((5)): (531-532). [PMID:24262462]
60. H T Benzon,M J Avram,D Green,R O Bonow. (2013-12-18) New oral anticoagulants and regional anaesthesia.. British journal of anaesthesia, 111 Suppl 1 (i96-113). [PMID:24335403]
61. B V Bloch,V Patel,A J Best. (2014-01-08) Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement.. The bone & joint journal, 96-B ((1)): (122-126). [PMID:24395322]
62. Robert Gosselin,Emily Hawes,Stephan Moll,Dorothy Adcock. (2014-01-18) Performance of various laboratory assays in the measurement of dabigatran in patients receiving therapeutic doses: a prospective study based on peak and trough plasma levels.. American journal of clinical pathology, 141 ((2)): (262-267). [PMID:24436275]
63. John W Eikelboom,Martina Brueckmann,Frans Van de Werf. (2014-01-24) Dabigatran in patients with mechanical heart valves.. The New England journal of medicine, 370 ((4)): (383-384). [PMID:24450899]
64. Piero Stratta,Michele Battista,Gabriele Guglielmetti. (2014-01-24) Dabigatran in patients with mechanical heart valves.. The New England journal of medicine, 370 ((4)): (381-381). [PMID:24450900]
65. Alexander Speirs,Adam Deakin. (2014-01-24) Dabigatran in patients with mechanical heart valves.. The New England journal of medicine, 370 ((4)): (382-382). [PMID:24450902]
66. Michael P Miller,Toby C Trujillo,Kristen E Nordenholz. (2014-02-12) Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants.. The American journal of emergency medicine, 32 ((4)): (375-382). [PMID:24512886]
67. Partha Sardar,Ramez Nairooz,Saurav Chatterjee,Jørn Wetterslev,Joydeep Ghosh,Wilbert S Aronow. (2014-02-12) Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation.. The American journal of cardiology, 113 ((7)): (1173-1177). [PMID:24513472]
68. Torben Bjerregaard Larsen,Anders Gorst-Rasmussen,Lars Hvilsted Rasmussen,Flemming Skjøth,Mary Rosenzweig,Gregory Y H Lip. (2014-02-18) Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.. The American journal of medicine, 127 ((7)): (650-656). [PMID:24530792]
69. Alicia Molinier,Blandine Acket,Robert Bourrel,Orso Lavezzi,Jean-Louis Montastruc,Haleh Bagheri. (2014-02-19) [Extrapolation of physiopathological data to clinical practice: Example of dabigatran in off-label use].. Presse medicale (Paris, France : 1983), 43 ((4 Pt 1)): (468-469). [PMID:24534477]
70. Ajay Yadlapati,Christopher Groh,Rod Passman. (2014-03-01) Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter.. The American journal of cardiology, 113 ((8)): (1362-1363). [PMID:24576547]
71. Henna Wong,David Keeling. (2014-03-13) Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding.. British journal of haematology, 166 ((1)): (152-153). [PMID:24617554]
72. Stuart E Lind,Mary Ellen Boyle,Sheila Fisher,Jan Ishimoto,Toby C Trujillo,Tyree H Kiser. (2014-04-10) Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples.. American journal of clinical pathology, 141 ((5)): (665-674). [PMID:24713737]
73. Jecko Thachil. (2014-04-10) The newer direct oral anticoagulants: a practical guide.. Clinical medicine (London, England), 14 ((2)): (165-175). [PMID:24715128]
74. Alex Gallus. (2014-04-16) ACP Journal Club. Review: Dabigatran does not differ from vitamin K antagonists for mortality or major bleeding.. Annals of internal medicine, 160 ((8)): (JC5-JC5). [PMID:24733222]
75. Benjamin A Steinberg,Jonathan P Piccini. (2014-04-16) Anticoagulation in atrial fibrillation.. BMJ (Clinical research ed.), 348 (g2116-g2116). [PMID:24733535]
76. A Lai,N Davidson,S W Galloway,J Thachil. (2014-04-30) Perioperative management of patients on new oral anticoagulants.. The British journal of surgery, 101 ((7)): (742-749). [PMID:24777590]
77. Johann Steurer. (2014-05-08) [Not Available].. Praxis, 103 ((10)): (602-602). [PMID:24800774]
78. W L Baker,K W Chamberlin. (2014-06-20) New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?. Clinical pharmacology and therapeutics, 96 ((1)): (17-19). [PMID:24942397]
79. Saurav Chatterjee,Partha Sardar,Jay S Giri,Joydeep Ghosh,Debabrata Mukherjee. (2014-07-06) Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients.. Mayo Clinic proceedings, 89 ((7)): (896-907). [PMID:24996233]
80. Khine Win,George M Rodgers. (2014-07-22) New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.. American journal of hematology, 89 ((10)): (1017-1017). [PMID:25043836]
81. (2014-07-22) Treatment of atrial fibrillation.. The Medical letter on drugs and therapeutics, 56 ((1446)): (53-58). [PMID:25046325]
82. Deborah Cohen. (2014-07-25) Dabigatran: how the drug company withheld important analyses.. BMJ (Clinical research ed.), 349 (g4670-g4670). [PMID:25055829]
83. Blake Charlton,Rita Redberg. (2014-07-25) The trouble with dabigatran.. BMJ (Clinical research ed.), 349 (g4681-g4681). [PMID:25055830]
84. Deborah Cohen. (2014-07-25) Concerns over data in key dabigatran trial.. BMJ (Clinical research ed.), 349 (g4747-g4747). [PMID:25055831]
85. Thomas J Moore,Michael R Cohen,Donald R Mattison. (2014-07-25) Dabigatran, bleeding, and the regulators.. BMJ (Clinical research ed.), 349 (g4517-g4517). [PMID:25056265]
86. Partha Sardar,Saurav Chatterjee,Eyal Herzog,Ramez Nairooz,Debabrata Mukherjee,Jonathan L Halperin. (2014-07-30) Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials.. The Canadian journal of cardiology, 30 ((8)): (888-897). [PMID:25064581]
87. Dorothea Baumann,Michael Haap,Christos Tsaousidis,Bernhard Krämer,Jürgen Schreieck,Karl Jaschonek,Ingo Rettig,Andreas Peter,Diethelm Wallwiener,Ferruh Artunc. (2014-07-30) [Vaginal bleeding as symptom of a medical emergency--pitfalls of therapy with new oral anticoagulants - case 5/2014].. Deutsche medizinische Wochenschrift (1946), 139 ((30)): (1539-1539). [PMID:25072863]
88. Adam J McShane,Yuanyuan Shen,Mary Joan Castillo,Xudong Yao. (2014-08-06) Peptide dimethylation: fragmentation control via distancing the dimethylamino group.. Journal of the American Society for Mass Spectrometry, 25 ((10)): (1694-1704). [PMID:25091822]
89. Mary S Vaughan Sarrazin,Michael Jones,Alexander Mazur,Elizabeth Chrischilles,Peter Cram. (2014-08-12) Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.. The American journal of medicine, 127 ((12)): (1179-1185). [PMID:25107386]
90. Torben Bjerregaard Larsen,Lars Hvilsted Rasmussen,Anders Gorst-Rasmussen,Flemming Skjøth,Deirdre A Lane,Gregory Y H Lip. (2014-09-07) Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.. The American journal of medicine, 127 ((12)): (1172-1178). [PMID:25193361]
91. Stuart J Connolly,Lars Wallentin,Salim Yusuf. (2014-09-25) Additional events in the RE-LY trial.. The New England journal of medicine, 371 ((15)): (1464-1465). [PMID:25251519]
92. Stephan Kadauke,Bernard Khor,Elizabeth M Van Cott. (2014-10-09) Activated protein C resistance testing for factor V Leiden.. American journal of hematology, 89 ((12)): (1147-1150). [PMID:25293789]
93. Vikash Pandey,Marc Sultan,Karl Kashofer,Meryem Ralser,Vyacheslav Amstislavskiy,Julia Starmann,Ingrid Osprian,Christina Grimm,Hendrik Hache,Marie-Laure Yaspo,Holger Sültmann,Michael Trauner,Helmut Denk,Kurt Zatloukal,Hans Lehrach,Christoph Wierling. (2014-10-28) Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains.. PloS one, 9 ((10)): (e111006-e111006). [PMID:25347188]
94. David J Graham,Marsha E Reichman,Michael Wernecke,Rongmei Zhang,Mary Ross Southworth,Mark Levenson,Ting-Chang Sheu,Katrina Mott,Margie R Goulding,Monika Houstoun,Thomas E MaCurdy,Chris Worrall,Jeffrey A Kelman. (2014-11-02) Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.. Circulation, 131 ((2)): (157-164). [PMID:25359164]
95. Rita F Redberg. (2014-11-05) The importance of postapproval data for dabigatran.. JAMA internal medicine, 175 ((1)): (25-25). [PMID:25365377]
96. Inmaculada Hernandez,Seo Hyon Baik,Antonio Piñera,Yuting Zhang. (2014-11-05) Risk of bleeding with dabigatran in atrial fibrillation.. JAMA internal medicine, 175 ((1)): (18-24). [PMID:25365537]
97. J Beyer-Westendorf. (2014-11-08) [Bleeding complications under oral anticoagulation].. Deutsche medizinische Wochenschrift (1946), 139 ((49)): (2491-2493). [PMID:25376450]
98. Estella M Davis,Erin M Uhlmeyer,David P Schmidt,Greg L Schardt. (2014-12-09) Strategies for urgent reversal of target-specific oral anticoagulants.. Hospital practice (1995), 42 ((5)): (108-125). [PMID:25485923]
99. Dirk Einecke. (2015-01-23) [Fewer strokes, lower mortality. Large general practice studies confirm good safety profile of dabigatran].. MMW Fortschritte der Medizin, 156 ((21-22)): (28-28). [PMID:25608388]
100. Susann Hasler. (2015-01-30) [Dabigatran and risk of bleeding].. Praxis, 104 ((3)): (157-158). [PMID:25626386]
101. Li Feng,Yanjun Xu,Yunpeng Zhang,Zeguo Sun,Junwei Han,Chunlong Zhang,Haixiu Yang,Desi Shang,Fei Su,Xinrui Shi,Shang Li,Chunquan Li,Xia Li. (2015-10-17) Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies.. Oncotarget, 6 ((36)): (39151-39164). [PMID:26472186]
102. G D Heggie,J P Sommadossi,D S Cross,W J Huster,R B Diasio. (1987-04-15) Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.. Cancer research, 47 ((8)): (2203-2206). [PMID:3829006]
103. T W Traut,M E Jones. (1996-01-01) Uracil metabolism--UMP synthesis from orotic acid or uridine and conversion of uracil to beta-alanine: enzymes and cDNAs.. Progress in nucleic acid research and molecular biology, 53 (1-78). [PMID:8650301]
104. R C Harris,M J Tallon,M Dunnett,L Boobis,J Coakley,H J Kim,J L Fallowfield,C A Hill,C Sale,J A Wise. (2006-03-24) The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis.. Amino acids, 30 ((3)): (279-289). [PMID:16554972]
105. Jiro Arima,Masazumi Morimoto,Hirokazu Usuki,Nobuhiro Mori,Tadashi Hatanaka. (2010-03-23) Beta-alanyl peptide synthesis by Streptomyces S9 aminopeptidase.. Journal of biotechnology, 147 ((1)): (52-58). [PMID:20303368]
106. Jan Heyland,Nicolai Antweiler,Jochen Lutz,Tobias Heck,Birgit Geueke,Hans-Peter E Kohler,Lars M Blank,Andreas Schmid. (2011-01-25) Simple enzymatic procedure for L-carnosine synthesis: whole-cell biocatalysis and efficient biocatalyst recycling.. Microbial biotechnology, 3 ((1)): (74-83). [PMID:21255308]
107. Yanhui Yang,Peng Gao,Yishuang Liu,Xinyue Ji,Maoluo Gan,Yan Guan,Xueqin Hao,Zhuorong Li,Chunling Xiao. (2011-06-07) A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.. Bioorganic & medicinal chemistry letters, 21 ((13)): (3943-3946). [PMID:21641210]
108. Trent Stellingwerff,Jacques Decombaz,Roger C Harris,Chris Boesch. (2012-02-24) Optimizing human in vivo dosing and delivery of β-alanine supplements for muscle carnosine synthesis.. Amino acids, 43 ((1)): (57-65). [PMID:22358258]
109. Jay R Hoffman,Nadia S Emerson,Jeffrey R Stout. (2012-07-11) β-Alanine supplementation.. Current sports medicine reports, 11 ((4)): (189-195). [PMID:22777329]
110. Lorenz Breuer,Jürgen Ringwald,Stefan Schwab,Martin Köhrmann. (2013-06-21) Ischemic stroke in an obese patient receiving dabigatran.. The New England journal of medicine, 368 ((25)): (2440-2442). [PMID:23782198]
111. L O Melkonian,G E Avetisova,A A Ambartsumian,A Kh Chakhalian,A S Sagian. (2013-06-26) [Regulation of key enzymes of L-alanine biosynthesis by Brevibacterium flavum producer strains].. Prikladnaia biokhimiia i mikrobiologiia, 49 ((2)): (144-148). [PMID:23795472]
112. Syed Habibullah Kamran,Syeda Maria Muzammil,Ayeesha Kamran Kamal. (2013-07-20) What are the new therapeutic alternatives to warfarin in atrial fibrillation?. JPMA. The Journal of the Pakistan Medical Association, 63 ((1)): (129-130). [PMID:23865151]
113. Khaled Abass,Petri Reponen,Sampo Mattila,Arja Rautio,Olavi Pelkonen. (2013-09-11) Human variation and CYP enzyme contribution in benfuracarb metabolism in human in vitro hepatic models.. Toxicology letters, 224 ((2)): (300-309). [PMID:24016712]
114. Theodore J Kolias. (2013-12-18) ACP Journal Club. Dabigatran increased bleeding and stroke compared with warfarin after mechanical heart valve implantation.. Annals of internal medicine, 159 ((12)): (JC6-JC6). [PMID:24343411]
115. Nancy M Albert. (2014-01-01) Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.. Heart & lung : the journal of critical care, 43 ((1)): (48-59). [PMID:24373340]
116. Sam Schulman,Bruce Ritchie,Jennifer K Goy,Susan Nahirniak,Mohammad Almutawa,Shari Ghanny. (2014-01-05) Activated prothrombin complex concentrate for dabigatran-associated bleeding.. British journal of haematology, 164 ((2)): (308-310). [PMID:24383848]
117. Jan Hendrik Schaefer,Wendy Leung,Limin Wu,Elizabeth M Van Cott,Josephine Lok,Michael Whalen,Klaus van Leyen,Arne Lauer,Joanne van Ryn,Eng H Lo,Christian Foerch. (2014-02-20) Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 34 ((5)): (870-875). [PMID:24549187]
118. Hugh Calkins,Edward P Gerstenfeld,Richard Schilling,Atul Verma,Stephan Willems. (2014-12-03) RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy.. The American journal of cardiology, 115 ((1)): (154-155). [PMID:25456859]
119. Elena Ashikhmina,Nicole Tomasello,Jean Marie Connors,Jama Jahanyar,Michael Davidson,K Annette Mizuguchi. (2014-12-04) Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest.. The Annals of thoracic surgery, 98 ((6)): (2215-2216). [PMID:25468095]
120. Zelai Li, Maohong Fan, Ge Gao, Wufeng Jiang, Xiaoshan Li, Cong Luo, Liqi Zhang, Fan Wu. (2024) Potassium β–alanine – A promising agent for reducing carbon capture cost via electrochemically mediated amine regeneration. SEPARATION AND PURIFICATION TECHNOLOGY, 334 (125984). [10.1016/j.seppur.2023.125984]
121. Wei Hu, Jingchun Huang, Junwen Wang, Di Xie, Zhenqi Wang, Yu Qiao, Minghou Xu. (2024) Benign-by-design N-doped activated carbon from wasted aqueous assisted hydrochar of leftover rice for efficient H2S removal. FUEL, 358 (130233). [10.1016/j.fuel.2023.130233]
122. Ziyang Huang, Mingyang Guan, Ziting Bao, Fengyi Dong, Xiaolin Cui, Guozhen Liu. (2023) Ligand Mediation for Tunable and Oxide Suppressed Surface Gold-Decorated Liquid Metal Nanoparticles. Small, (2306652). [PMID:37806762] [10.1002/smll.202306652]
123. Wenting Li, Hanjie Zhang, Sijie Huang, Jingyi Xu, Liping Liu, Junshan Li, Jianfang Jing, Yongfa Zhu. (2024) Electron-enriched supramolecular PDI-SiO2 promoting PDS activation for enhanced photocatalytic advanced oxidation. APPLIED CATALYSIS B-ENVIRONMENTAL, 340 (123262). [10.1016/j.apcatb.2023.123262]
124. Rong Ji, Yuming Dong, Hui Zhao, Chengsi Pan, Guangli Wang, Yongfa Zhu, Junshan Li. (2023) Z-scheme cobalt-iron oxide/perylene diimide supermolecule heterojunction for high-efficiency ciprofloxacin removal in a photocatalysis-self-Fenton system. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 648 (623). [PMID:37321081] [10.1016/j.jcis.2023.05.180]
125. Hui Xu, Chaohua Peng, Long Xia, Zhongxi Miao, Siyuan He, Cheng Chi, Weiang Luo, Guorong Chen, Birong Zeng, Shuchuan Wang, Lizong Dai. (2023) A Novel Anderson-Type POMs-Based Hybrids Flame Retardant for Reducing Smoke Release and Toxicity of Epoxy Resins. MACROMOLECULAR RAPID COMMUNICATIONS, 44 (17): (2300162). [PMID:37114515] [10.1002/marc.202300162]
126. Kaiyang Shi, Man Zhou, Fulin Wang, Xiangwei Li, Weiya Huang, Kangqiang Lu, Kai Yang, Changlin Yu. (2023) Perylene diimide/iron phthalocyanine Z-scheme heterojunction with strong interfacial charge transfer through π-π interaction: Efficient photocatalytic degradation of tetracycline hydrochloride. CHEMOSPHERE, 329 (138617). [PMID:37037355] [10.1016/j.chemosphere.2023.138617]
127. Ziyang Lu, Bing Li, Xiaodie Zhu, Yangrui Xu, Jutao Zhang, Guosheng Zhou, Binghui Wei, Xinlin Liu, Jinyu Chu, Chundu Wu. (2023) IM-PDI/ZFO S-scheme heterojunction assembled by mutual magnetic attraction towards enhancing selective photodegradation ability. INORGANIC CHEMISTRY COMMUNICATIONS, 152 (110716). [10.1016/j.inoche.2023.110716]
128. Hai-Bin Qin, Jun-Ping Zhou, Bo Zhang, Zhi-Qiang Liu, Yu-Guo Zheng. (2022) Combing with redox regulation via quorum-sensing system and fermentation strategies for improving D-pantothenic acid production. PROCESS BIOCHEMISTRY, 121 (681). [10.1016/j.procbio.2022.08.012]
129. Ge Gao, Xiaoshan Li, Wufeng Jiang, Zhenghong Zhao, Yongqing Xu, Fan Wu, Cong Luo, Liqi Zhang. (2022) Improved quasi-cycle capacity method based on microcalorimetry strategy for the fast screening of amino acid salt absorbents for CO2 capture. SEPARATION AND PURIFICATION TECHNOLOGY, 289 (120767). [10.1016/j.seppur.2022.120767]
130. Yangrui Xu, Xiaodie Zhu, Huan Yan, Panpan Wang, Minshan Song, Changchang Ma, Ziran Chen, Jinyu Chu, Xinlin Liu, Ziyang Lu. (2022) Hydrochloric acid-mediated synthesis of ZnFe2O4 small particle decorated one-dimensional Perylene Diimide S-scheme heterojunction with excellent photocatalytic ability. CHINESE JOURNAL OF CATALYSIS, 43 (1111). [10.1016/S1872-2067(21)63930-X]
131. Wenwu Zhou, Bing Yang, Guo Liu, Chenmin Xu, Qiuyi Ji, Weiming Xiang, Dunyu Sun, Qiang Zhong, Huan He, Liu Yazi, Zhe Xu, Chengdu Qi, Shiyin Li, Shaogui Yang. (2022) Perylene diimide supermolecule (PDI) as a novel and highly efficient cocatalyst for photocatalytic degradation of tetracycline in water: A case study of PDI decorated graphitic carbon nitride/bismuth tungstate composite. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 615 (849). [PMID:35182855] [10.1016/j.jcis.2022.02.003]
132. Haoyi Wang, Ye Zhou, Jinnan Wang, Aimin Li, Philippe François-Xavier Corvini. (2022) BiOBr/ Bi4O5Br2/PDI constructed for visible-light degradation of endocrine disrupting chemicals: Synergistic effects of bi-heterojunction and oxygen evolution. CHEMICAL ENGINEERING JOURNAL, 433 (133622). [10.1016/j.cej.2021.133622]
133. Xuejia Chen, Tingkai Xiong, Jin Xu, Yan Li, Min Zhang, Ying Liang. (2021) Determination of ammonium in natural water using a quinoline-based o-dialdehyde fluorescent reagent with visible excitation wavelength. Analytical Methods, 13 (43): (5231-5239). [PMID:34704564] [10.1039/D1AY01462E]
134. Wenlong Zhang, Jincheng Mao, Zhenfu Jia, Xiaojiang Yang, Peng Zhang, Xiaodong Su, Chengyu Zhou, Dan Bao, Wenbi Zeng. (2021) Design of a salt-tolerant Gemini viscoelastic surfactant and the study of construction of wormlike micelle structure in high-salinity aqueous environment. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 631 (127653). [10.1016/j.colsurfa.2021.127653]
135. Bo Zhang, Li Chen, Jie-Yi Jin, Na Zhong, Xue Cai, Shu-Ping Zou, Hai-Yan Zhou, Zhi-Qiang Liu, Yu-Guo Zheng. (2021) Strengthening the (R)-pantoate pathway to produce D-pantothenic acid based on systematic metabolic analysis. Food Bioscience, 43 (101283). [10.1016/j.fbio.2021.101283]
136. Yingying You, Haiguang Yuan, Yixiao Wu, Yiyang Ma, Chenchen Meng, Xuesong Zhao. (2021) A novel red phosphorus/perylene diimide metal-free photocatalyst with p-n heterojunctions for efficient photoreduction of bromate under visible light. SEPARATION AND PURIFICATION TECHNOLOGY, 264 (118456). [10.1016/j.seppur.2021.118456]
137. Fei Mingyue, Mao Xudan, Chen Yiyang, Lu Yalan, Wang Lin, Yang Jie, Qiu Juanping, Sun Dongchang. (2020) Development of a dual-fluorescence reporter system for high-throughput screening of L-aspartate-α-decarboxylase. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 52 (12): (1420-1426). [PMID:33313655] [10.1093/abbs/gmaa134]
138. Luyao Su, Jie Mao, Sui Wang, Yufang Hu. (2020) A bimodal electrochemiluminescence method based on dual-enhancement Ru(bpy)32+/CQDs/AA system combined with magnetic field enhanced solid-phase microextraction for the direct determination of ascorbic acid. JOURNAL OF ELECTROANALYTICAL CHEMISTRY, 873 (114376). [10.1016/j.jelechem.2020.114376]
139. Lili Zhang, Wen Duan, Yan Huang, Yuyu Zhang, Baoguo Sun, Dandan Pu, Yizhuang Tang, Chao Liu. (2020) Sensory taste properties of chicken (Hy-Line brown) soup as prepared with five different parts of the chicken. INTERNATIONAL JOURNAL OF FOOD PROPERTIES, [10.1080/10942912.2020.1828455]
140. Tao Cai, Wengao Zeng, Yutang Liu, Longlu Wang, Wanyue Dong, Hui Chen, Xinnian Xia. (2020) A promising inorganic-organic Z-scheme photocatalyst Ag3PO4/PDI supermolecule with enhanced photoactivity and photostability for environmental remediation. APPLIED CATALYSIS B-ENVIRONMENTAL, 263 (118327). [10.1016/j.apcatb.2019.118327]
141. Wengao Zeng, Tao Cai, Yutang Liu, Longlu Wang, Wanyue Dong, Hui Chen, Xinnian Xia. (2020) An artificial organic-inorganic Z-scheme photocatalyst WO3@Cu@PDI supramolecular with excellent visible light absorption and photocatalytic activity. CHEMICAL ENGINEERING JOURNAL, 381 (122691). [10.1016/j.cej.2019.122691]
142. Xiucai Guo, Wei Li, Qingmei Li, Yan Chen, Guode Zhao, Ying Peng, Jiang Zheng. (2019) Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4. CHEMICAL RESEARCH IN TOXICOLOGY, 32 (9): (1791–1800). [PMID:31414593] [10.1021/acs.chemrestox.9b00141]
143. Jin Hu, Weiwei Wei, Shanming Ke, Xierong Zeng, Peng Lin. (2019) A novel and sensitive sarcosine biosensor based on organic electrochemical transistor. ELECTROCHIMICA ACTA, 307 (100). [10.1016/j.electacta.2019.03.180]
144. Xiao Y. Luo, Xiao Y. Lv, Gui L. Shi, Qin Meng, Hao R. Li, Cong M. Wang. (2018) Designing amino-based ionic liquids for improved carbon capture: One amine binds two CO2. AICHE JOURNAL, 65 (1): (230-238). [10.1002/aic.16420]
145. Zhang Zhi-Jun, Cai Rui-Feng, Xu Jian-He. (2018) Characterization of a new nitrilase from Hoeflea phototrophica DFL-43 for a two-step one-pot synthesis of (S)-β-amino acids. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 102 (14): (6047-6056). [PMID:29744634] [10.1007/s00253-018-9057-7]
146. Dandan Han, Yumin Liu, Xiaona Li, Teng Zhang, Zhenfang Li, Shichao Du, Mingxia Guo, Shijie Xu, Bo Yu, Baohong Hou, Junbo Gong. (2017) Effect of β-alanine and the solvent composition on the solubility of solvate of calcium d-pantothenate containing four molecules of methanol and one molecule of water (D-PC·4MeOH·1H2O). JOURNAL OF CHEMICAL THERMODYNAMICS, 106 (36). [10.1016/j.jct.2016.11.011]
147. Sihua Guo, Fangyuan Zheng, Fang Zeng, Shuizhu Wu. (2016) A fluorescent probe capable of discriminately and simultaneously detecting dl-dithiothreitol and single sulfhydryl-containing thiols. SENSORS AND ACTUATORS B-CHEMICAL, 224 (88). [10.1016/j.snb.2015.10.036]
148. Yansong Li, Shiying Lu, Zengshan Liu, Lihui Sun, Junfei Guo, Pan Hu, Junhui Zhang, Yuanyuan Zhang, Yang Wang, Honglin Ren, Xingyu Meng, Yu Zhou. (2015) A monoclonal antibody based enzyme-linked immunosorbent assay for detection of phenylethanolamine A in tissue of swine. FOOD CHEMISTRY, 167 (40). [PMID:25148957] [10.1016/j.foodchem.2014.06.085]
149. Lu Zhang, Zijian Zhang, Chaozheng He, Liming Dai, Jun Liu, Lixiang Wang. (2014) Rationally Designed Surfactants for Few-Layered Graphene Exfoliation: Ionic Groups Attached to Electron-Deficient π-Conjugated Unit through Alkyl Spacers. ACS Nano, 8 (7): (6663–6670). [PMID:24968119] [10.1021/nn502289w]
150. Duan-Jian Tao, Zheng Cheng, Feng-Feng Chen, Zhang-Min Li, Na Hu, Xiang-Shu Chen. (2013) Synthesis and Thermophysical Properties of Biocompatible Cholinium-Based Amino Acid Ionic Liquids. JOURNAL OF CHEMICAL AND ENGINEERING DATA, 58 (6): (1542–1548). [10.1021/je301103d]
151. Zhihong Zhang, Guijuan Li, Fufeng Yan, Zhonghou Zhang, Shaoming Fang. (2012) Highly Sensitive Functionalized Conducting Copolypyrrole Film for DNA Sensing and Protein-resistant. CHINESE JOURNAL OF CHEMISTRY, 30 (2): (259-266). [10.1002/cjoc.201100078]
152. Chai Xinhan, Huang Weiqiu, Li Xufei, Wang Xinya, Zhou Yankang, Zhu Bing, Li Yuning, Tian Xinchen. (2024) Amino Acid-Modified Porous Carbon Foams Derived from Wheat Powder with Enhanced Adsorption Performance for VOCs. KOREAN JOURNAL OF CHEMICAL ENGINEERING, 41 (8): (2321-2334). [10.1007/s11814-024-00195-1]
153. Haixin Gao, Qiang Fang, Yanfen Bai, Chunyue Hu, Howard H. Chou. (2025) Biosynthesis of 12-aminododecanoic acid from biomass sugars. METABOLIC ENGINEERING, 89 (87). [PMID:39999943] [10.1016/j.ymben.2025.02.010]
154. Lu Wang, Limei Xiao, Shoujing Zheng, Jie Pang, Jiebo Chen. (2024) Characterization and assessment of free amino acids in different varieties of sugarcane. INDUSTRIAL CROPS AND PRODUCTS, 212 (118306). [10.1016/j.indcrop.2024.118306]
155. Meisi Chen, Weida Chen, Bin Jiang, Ying Huang, Tong Lei, Feng Zhang, Youting Wu. (2024) Functional ionic liquid as phase separation trigger in biphasic absorption of CO2. CHEMICAL ENGINEERING JOURNAL, 485 (149648). [10.1016/j.cej.2024.149648]
156. Jinming Hu, Shuo Zhang, Mengmeng Li, Guangyong Zhao. (2024) Impact of dietary supplementation with β-alanine on rumen microbial crude protein supply, nutrient digestibility and nitrogen retention of beef steers elucidated through sequencing the rumen bacterial community. Animal Nutrition, [PMID:38808018] [10.1016/j.aninu.2024.02.006]
157. Linlin Zheng, Xuechuan Lv, Yanan Chen, Bingyu Wei, Wanqing Hao, Ziyi Zhang, Jingru Yang, Ruiyu Liu, Xu Zhu, Yanli Zhou, Maotian Xu, Xiaohan Gao, Hui Dong. (2024) In Situ NH2-MIL-101(Fe) Nanoparticles Modified Pencil Core Electrodes for Simultaneous Ratiometric Electrochemical Detection of Caffeic Acid and Acetaminophen. ACS Applied Nano Materials, 7 (14): (16295-16305). [10.1021/acsanm.4c02317]
158. Yu Yang, Xianbing Song, Manman Wang, Xiaolian Li, Ziqiang Wang, Peng Wang. (2025) Molecular modification of l-aspartate-α-decarboxylase and multi-enzyme catalytic preparation of β-alanine. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 713 (136543). [10.1016/j.colsurfa.2025.136543]
159. Yongzhang Xu, Xingrui Luo, Fulin Wang, Wentao Xiang, Chensheng Zhou, Weiya Huang, Kangqiang Lu, Shaoyu Li, Man Zhou, Kai Yang. (2024) Novel PDI-NH/PDI-COOH Supramolecular Junction for Enhanced Visible-Light Photocatalytic Phenol Degradation. MOLECULES, 29 (17): (4196). [PMID:39275044] [10.3390/molecules29174196]
160. Dongyu Wang, Yujuan Pu, JuFeng Li, Yong Zhai, Qingwei Wang, Ligang Wang, Yunchuan Yang, Jisheng Geng, Quanwei Song, Jun Wang, Yongfa Zhu. (2025) Selective mineralization of phenolic pollutants via non-radical pathways: A photochemical direct charge transfer mechanism based on peryleneimide (PDI). CHEMICAL ENGINEERING JOURNAL, 504 (159002). [10.1016/j.cej.2024.159002]
161. Lin Xinyu, Hao Yue, Gong Yanjun, Zhou Peng, Ma Dongge, Liu Zhonghuan, Sun Yuming, Sun Hongyang, Chen Yahui, Jia Shuhan, Li Wanhe, Guo Chengqi, Zhou Yiying, Huo Pengwei, Yan Yan, Ma Wanhong, Yuan Shouqi, Zhao Jincai. (2024) Solar overall water-splitting by a spin-hybrid all-organic semiconductor. Nature Communications, 15 (1): (1-10). [PMID:38871750] [10.1038/s41467-024-49511-7]
162. Linting Jiang, Lu Yang, Xue Yi, Shengtao Zhang, Hongru Li, Zhiyong Wang, Fang Gao. (2025) Strengthened Zinc Anode by Trace Natural Amino Acid β-Alanine in Aqueous Electrolyte Inspired by Synial Membrane: An Experimental Survey. LANGMUIR, 41 (13): (9046-9056). [PMID:40134315] [10.1021/acs.langmuir.5c00525]
163. Congzhi Hu, Yuye Li, Tingting Du, Youyong Pang, Yongping Liu, Botian Liu, Ling Li, Huidan Lu, Bin Huang. (2025) Study on the mechanism of photocatalytic activity enhancement of Ag/Ag3PO4/PDI-2 supramolecular Z-scheme heterojunction photocatalyst. Materials Science and Engineering B-Advanced Functional Solid-State Materials, 311 (117845). [10.1016/j.mseb.2024.117845]
164. Yuhang Ren, Yu Tian, Yating Lu, Dongyu Nie, Huayi Zhu, Xia Yang. (2024) Z-scheme H-PDI supermolecule/NH2-MIL-101(Fe) for enhanced malathion degradation: Mechanism, pathway, and toxicity assessment. Journal of Environmental Chemical Engineering, 12 (114358). [10.1016/j.jece.2024.114358]

溶液计算器

摩尔浓度计算器

计算溶液所需的质量、体积或浓度。

质量

浓度

体积

分子量

g/mol

稀释计算器

计算配制储备溶液所需的稀释度。

浓度1（C1）

体积 1 (V1)

浓度 2 (C2)

体积 2 (V2)

复溶计算器

复溶计算器允许您快速计算试剂的体积，以复溶小瓶。只需输入试剂的质量和目标浓度，计算器将确定其余部分。

体积（添加到小瓶中）

质量（小瓶）

所需的复溶浓度

货号 (SKU)	包装规格	是否现货
A105703-25g	25g	现货
A105703-100g	100g	现货
A105703-500g	500g	现货
A105703-2.5kg	2.5kg	现货

β-丙氨酸

库存信息

库存信息

库存信息

库存信息

基本描述

关联靶点（人）

关联靶点（其它种属）

作用机制

名称和识别符

化学和物理性质

安全和危险性（GHS）

质检证书（CoA,COO,BSE/TSE 和分析图谱)

显示更多⌵

可替换产品

此产品的引用文献

引用文献

溶液计算器

摩尔浓度计算器

稀释计算器

复溶计算器